Quote Originally Posted by AdamVR4 View Post
Assuming the larger sample-size testing goes well, how long until this could potentially be part of the recommended treatment for MS?
Usually after stage III of trials, it gets FDA/Health Canada approval for general treatment. From Glossary - ClinicalTrials.gov

PHASE I TRIALS: Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.

PHASE II TRIALS: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.

PHASE III TRIALS: Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling.

PHASE IV TRIALS: Post-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use.

Seeing as they're only up to stage II, it'll be probably at least a year, and that's very optimistic.

P.S. It says drugs, but I do believe the same stages apply to new treatments such as what's being suggested by Dr. Zamboni.